Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Lung Surfactant Protein Type B Levels As a Diagnostic and Prognostic Marker in Heart Failure Progression

NCT06896461 is registered in ClinicalTrials.gov with Centro Cardiologico Monzino as lead sponsor.

NCT NCT06896461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06896461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Lung Surfactant Protein Type B Levels As a Diagnostic and Prognostic Marker in Heart Failure Progression
Lead sponsor
Centro Cardiologico Monzino
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2016
Completion date
December 31, 2024
Enrollment
471 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure